File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Regulation of the PI3K pathway through a p85α monomer–homodimer equilibrium

TitleRegulation of the PI3K pathway through a p85α monomer–homodimer equilibrium
Authors
Issue Date2015
Citation
eLife, 2015, v. 4, n. JULY 2015 How to Cite?
Abstract© Cheung et al. The canonical action of the p85α regulatory subunit of phosphatidylinositol 3-kinase (PI3K) is to associate with the p110α catalytic subunit to allow stimuli-dependent activation of the PI3K pathway. We elucidate a p110α-independent role of homodimerized p85α in the positive regulation of PTEN stability and activity. p110α-free p85α homodimerizes via two intermolecular interactions (SH3:proline-rich region and BH:BH) to selectively bind unphosphorylated activated PTEN. As a consequence, homodimeric but not monomeric p85α suppresses the PI3K pathway by protecting PTEN from E3 ligase WWP2-mediated proteasomal degradation. Further, the p85α homodimer enhances the lipid phosphatase activity and membrane association of PTEN. Strikingly, we identified cancer patient-derived oncogenic p85α mutations that target the homodimerization or PTEN interaction surface. Collectively, our data suggest the equilibrium of p85α monomerdimers regulates the PI3K pathway and disrupting this equilibrium could lead to disease development.
Persistent Identifierhttp://hdl.handle.net/10722/225070

 

DC FieldValueLanguage
dc.contributor.authorCheung, Lydia W T-
dc.contributor.authorWalkiewicz, Katarzyna W.-
dc.contributor.authorBesong, Tabot Md-
dc.contributor.authorGuo, Huifang-
dc.contributor.authorHawke, David H.-
dc.contributor.authorArold, Stefan T.-
dc.contributor.authorMills, Gordon B.-
dc.date.accessioned2016-04-18T11:16:41Z-
dc.date.available2016-04-18T11:16:41Z-
dc.date.issued2015-
dc.identifier.citationeLife, 2015, v. 4, n. JULY 2015-
dc.identifier.urihttp://hdl.handle.net/10722/225070-
dc.description.abstract© Cheung et al. The canonical action of the p85α regulatory subunit of phosphatidylinositol 3-kinase (PI3K) is to associate with the p110α catalytic subunit to allow stimuli-dependent activation of the PI3K pathway. We elucidate a p110α-independent role of homodimerized p85α in the positive regulation of PTEN stability and activity. p110α-free p85α homodimerizes via two intermolecular interactions (SH3:proline-rich region and BH:BH) to selectively bind unphosphorylated activated PTEN. As a consequence, homodimeric but not monomeric p85α suppresses the PI3K pathway by protecting PTEN from E3 ligase WWP2-mediated proteasomal degradation. Further, the p85α homodimer enhances the lipid phosphatase activity and membrane association of PTEN. Strikingly, we identified cancer patient-derived oncogenic p85α mutations that target the homodimerization or PTEN interaction surface. Collectively, our data suggest the equilibrium of p85α monomerdimers regulates the PI3K pathway and disrupting this equilibrium could lead to disease development.-
dc.languageeng-
dc.relation.ispartofeLife-
dc.titleRegulation of the PI3K pathway through a p85α monomer–homodimer equilibrium-
dc.typeArticle-
dc.description.natureLink_to_subscribed_fulltext-
dc.identifier.doi10.7554/eLife.06866-
dc.identifier.scopuseid_2-s2.0-84938364539-
dc.identifier.volume4-
dc.identifier.issueJULY 2015-
dc.identifier.eissn2050-084X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats